Over
Dr Prajwol Shrestha is a Medical Oncologist practising at Calvary Mater Newcastle and Lake Macquarie Private Hospitals. He provides care across a range of cancer types, mainly GI, breast, skin and H&N cancers.
His early medical training was undertaken at Liverpool, Gosford and Nepean Hospitals, with completion of Basic Physician Training in 2018. Dr Shrestha completed his specialist training in Medical Oncology at Calvary Mater Newcastle and the Central Coast Cancer Centre. He subsequently undertook a fellowship in early-phase clinical trials at Chris O’Brien Lifehouse in Sydney. Prior to relocating to Newcastle, he also worked in a range of clinical settings across Queensland and South Australia.
Dr Shrestha’s emphasizes on individualised treatment with plan tailored to each patient’s clinical needs and preferences, with the aim of supporting both treatment outcomes and quality of life.
Alongside his clinical work, Dr Shrestha is actively involved in clinical research. He has a particular interest in biomarker-driven clinical trials and has undertaken research into liquid biopsy biomarkers in Centenary Institute, RPA. He is a member of several professional organisations, including the American Society of Clinical Oncology, the European Society of Medical Oncology, and the Medical Oncology Group of Australia. He has authored multiple peer-reviewed publications and has presented his work at national and international conferences.
His early medical training was undertaken at Liverpool, Gosford and Nepean Hospitals, with completion of Basic Physician Training in 2018. Dr Shrestha completed his specialist training in Medical Oncology at Calvary Mater Newcastle and the Central Coast Cancer Centre. He subsequently undertook a fellowship in early-phase clinical trials at Chris O’Brien Lifehouse in Sydney. Prior to relocating to Newcastle, he also worked in a range of clinical settings across Queensland and South Australia.
Dr Shrestha’s emphasizes on individualised treatment with plan tailored to each patient’s clinical needs and preferences, with the aim of supporting both treatment outcomes and quality of life.
Alongside his clinical work, Dr Shrestha is actively involved in clinical research. He has a particular interest in biomarker-driven clinical trials and has undertaken research into liquid biopsy biomarkers in Centenary Institute, RPA. He is a member of several professional organisations, including the American Society of Clinical Oncology, the European Society of Medical Oncology, and the Medical Oncology Group of Australia. He has authored multiple peer-reviewed publications and has presented his work at national and international conferences.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Prajwol Shrestha
Opleiding & training
-
2001–2007 MD · Medicine and Surgery
-
2007–2011 Residency · Oncologie
-
2011–2012 Fellowship · Subspecialty training
Carrière & aanstellingen
-
2011-09–2012-08 Junior consultant
Vergunningen & verzekering
Medische licenties
AU — Organización Médica Colegial de España (OMC)
Boardcertificeringen
European Board of Oncologie
Beroepsaansprakelijkheidsverzekering:
AmTrust Europe · 1,000,000 EUR dekking · No claims on file
Uitgevoerde procedures
| Procedure | Code | Levenslang aantal |
|---|---|---|
| GP consultation | 99213 | 2,258 |
| Annual physical exam | 99395 | 668 |
| Vaccination administration | 90471 | 2,340 |
| Minor procedure (skin) | 17110 | 851 |
Diensten & prijzen
| Dienst | Duur | Modaliteit | Prijs |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 720.00 EUR |
Praktijk, team & in praktijk
Video's
Onderzoek & publicaties
h-index: 17 · i10: 6
-
Outcomes of Oncologie in adults — a multi-centre cohort
DOI: 10.7976/euroclin.2025.0 · PMID: 37197950 · geciteerd door 122
-
European registry analysis of Oncologie outcomes
DOI: 10.1367/euroclin.2024.1 · PMID: 37903200 · geciteerd door 176
-
Outcomes of Oncologie in adults — a multi-centre cohort
DOI: 10.8106/euroclin.2023.2 · PMID: 39871204 · geciteerd door 134
Uitgenodigde lezingen
- Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
- Single-centre experience in Oncologie National Society Meeting · Gateshead · 2023 · oral abstract
Onderscheidingen & lidmaatschappen
Onderscheidingen
- 🏆 Top-rated Oncologie — Gateshead · EuroClinics Patient Choice · 2025 · regional
Lidmaatschappen
- WONCA Europe — Family Doctors — Member · Sinds 2012
- national college of family doctors — Member · Sinds 2012
- European Union of Medical Specialists (UEMS) — Member · Sinds 2012
Artikelen van deze arts
- Patient education Patient guide to Oncologie
- Awareness When should you see a oncologie?
Voor internationale patiënten
- Coördinator
- Patient liaison · prajwol.shrestha@euroclinics.example
- Geaccepteerde internationale verzekeringen
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Locatie
1 tagPatiëntbeoordelingen
4 geverifieerde recensies4.83
★★★★⯨
4 recensies
- Bedside Manner
- 4.9
- Knowledge
- 4.9
- Wait Time
- 4.6
- Staff Friendliness
- 4.9
- Ease Of Appointment
- 4.7
- Value For Money
- 4.8
- Would Recommend Pct
- 96.0
Deel uw ervaring — help andere patiënten de juiste arts te vinden. Schrijf een recensie →
Recente recensies
-
★★★★★ ✓ Geverifieerd Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Geverifieerd Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Geverifieerd Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.